Your browser doesn't support javascript.
loading
Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations.
Seow, Wei Jie; Matsuo, Keitaro; Hsiung, Chao Agnes; Shiraishi, Kouya; Song, Minsun; Kim, Hee Nam; Wong, Maria Pik; Hong, Yun-Chul; Hosgood, H Dean; Wang, Zhaoming; Chang, I-Shou; Wang, Jiu-Cun; Chatterjee, Nilanjan; Tucker, Margaret; Wei, Hu; Mitsudomi, Tetsuya; Zheng, Wei; Kim, Jin Hee; Zhou, Baosen; Caporaso, Neil E; Albanes, Demetrius; Shin, Min-Ho; Chung, Lap Ping; An, She-Juan; Wang, Ping; Zheng, Hong; Yatabe, Yasushi; Zhang, Xu-Chao; Kim, Young Tae; Shu, Xiao-Ou; Kim, Young-Chul; Bassig, Bryan A; Chang, Jiang; Ho, James Chung Man; Ji, Bu-Tian; Kubo, Michiaki; Daigo, Yataro; Ito, Hidemi; Momozawa, Yukihide; Ashikawa, Kyota; Kamatani, Yoichiro; Honda, Takayuki; Sakamoto, Hiromi; Kunitoh, Hideo; Tsuta, Koji; Watanabe, Shun-Ichi; Nokihara, Hiroshi; Miyagi, Yohei; Nakayama, Haruhiko; Matsumoto, Shingo.
Affiliation
  • Seow WJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Matsuo K; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
  • Hsiung CA; Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Shiraishi K; Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan.
  • Song M; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.
  • Kim HN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Wong MP; Department of Statistics, Sookmyung Women's University, Seoul, Republic of Korea.
  • Hong YC; Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea.
  • Hosgood HD; Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
  • Wang Z; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Chang IS; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Wang JC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Chatterjee N; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Tucker M; National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan.
  • Wei H; Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai, People's Republic of China.
  • Mitsudomi T; State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, People's Republic of China.
  • Zheng W; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Kim JH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Zhou B; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Caporaso NE; Division of Thoracic Surgery, Kinki University School of Medicine, Sayama, Japan.
  • Albanes D; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Shin MH; Department of Integrative Bioscience & Biotechnology, Sejong University, Seoul, Republic of Korea.
  • Chung LP; Department of Epidemiology, School of Public Health, China Medical University, Shenyang, People's Republic of China.
  • An SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Wang P; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Zheng H; Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea.
  • Yatabe Y; Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
  • Zhang XC; Guangdong Lung Cancer Institute, Medical Research Center and Cancer Center of Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Kim YT; Department of Radiotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China.
  • Shu XO; Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Kim YC; Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Central Hospital, Nagoya, Japan.
  • Bassig BA; Guangdong Lung Cancer Institute, Medical Research Center and Cancer Center of Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Chang J; Department of Thoracic and Cardiovascular Surgery, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Ho JC; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Ji BT; Lung and Esophageal Cancer Clinic, Chonnam National University Hwasun Hospital, Hwasun-eup, Republic of Korea.
  • Kubo M; Department of Internal Medicine, Chonnam National Univerisity Medical School, Gwangju, Republic of Korea.
  • Daigo Y; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Ito H; Department of Etiology & Carcinogenesis, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Momozawa Y; Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong.
  • Ashikawa K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Kamatani Y; Laboratory for Genotyping Development, Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan.
  • Honda T; Center for Antibody and Vaccine Therapy, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Sakamoto H; Department of Medical Oncology and Cancer Center, Shiga University of Medical Science, Otsu, Japan.
  • Kunitoh H; Division of Epidemiology & Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Tsuta K; Laboratory for Genotyping Development, Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan.
  • Watanabe SI; Laboratory for Genotyping Development, Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan.
  • Nokihara H; Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Miyagi Y; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.
  • Nakayama H; Division of Genetics, National Cancer Center Research Institute, Tokyo, Japan.
  • Matsumoto S; Department of Medical Oncology, Japanese Red Cross Medical Center, Tokyo, Japan.
Hum Mol Genet ; 26(2): 454-465, 2017 01 15.
Article in En | MEDLINE | ID: mdl-28025329
ABSTRACT
To evaluate associations by EGFR mutation status for lung adenocarcinoma risk among never-smoking Asian women, we conducted a meta-analysis of 11 loci previously identified in genome-wide association studies (GWAS). Genotyping in an additional 10,780 never-smoking cases and 10,938 never-smoking controls from Asia confirmed associations with eight known single nucleotide polymorphisms (SNPs). Two new signals were observed at genome-wide significance (P < 5 × 10-8), namely, rs7216064 (17q24.3, BPTF), for overall lung adenocarcinoma risk, and rs3817963 (6p21.3, BTNL2) which is specific to cases with EGFR mutations. In further sub-analyses by EGFR status, rs9387478 (ROS1/DCBLD1) and rs2179920 (HLA-DPB1) showed stronger estimated associations in EGFR-positive compared to EGFR-negative cases. Comparison of the overall associations with published results in Western populations revealed that the majority of these findings were distinct, underscoring the importance of distinct contributing factors for smoking and non-smoking lung cancer. Our results extend the catalogue of regions associated with lung adenocarcinoma in non-smoking Asian women and highlight the importance of how the germline could inform risk for specific tumour mutation patterns, which could have important translational implications.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Adenocarcinoma / Antigens, Nuclear / HLA-DP beta-Chains / ErbB Receptors / Butyrophilins / Lung Neoplasms / Membrane Proteins / Nerve Tissue Proteins Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Hum Mol Genet Journal subject: BIOLOGIA MOLECULAR / GENETICA MEDICA Year: 2017 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Adenocarcinoma / Antigens, Nuclear / HLA-DP beta-Chains / ErbB Receptors / Butyrophilins / Lung Neoplasms / Membrane Proteins / Nerve Tissue Proteins Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Hum Mol Genet Journal subject: BIOLOGIA MOLECULAR / GENETICA MEDICA Year: 2017 Type: Article Affiliation country: United States